Area of research
Cancer Research · Immunology
Research interest
Research focused on Cancer research and Colorectal cancer, with related work in Metastasis, STAT3, Baicalein. Notable publications include 'The current understanding on the impact of KRAS on colorectal cancer', 'Baicalein is a novel TLR4‐targeting therapeutics agent that inhibits TLR4/HIF‐1α/VEGF signaling pathway in colorectal cancer', and 'miR-7/TGF-β2 axis sustains acidic tumor microenvironment-induced lung cancer metastasis'.
Targeting LRBA triggers CTLA4 degradation and antitumor immunity for cancer immunotherapy
Salvianolic acid B alleviates autoimmunity in Treg‐deficient mice via inhibiting <scp>IL2‐STAT5</scp> signaling
Brevilin A is a potent anti-metastatic CRC agent that targets the VEGF-IL6-STAT3 axis in the HSCs-CRC interplay
Brevilin A exerts anti-colorectal cancer effects and potently inhibits STAT3 signaling in vitro
Centipeda minima: An update on its phytochemistry, pharmacology and safety
The current understanding on the impact of KRAS on colorectal cancer
Baicalein is a novel TLR4‐targeting therapeutics agent that inhibits TLR4/HIF‐1α/VEGF signaling pathway in colorectal cancer
miR-7/TGF-β2 axis sustains acidic tumor microenvironment-induced lung cancer metastasis
Medicinal herbs and bioactive compounds overcome the drug resistance to epidermal growth factor receptor inhibitors in non‑small cell lung cancer (Review)
Baicalein Binds to TLR4, Inhibits Colorectal Cancer Growth and Metastasis via the TLR4/HIF/VEGF Axis